Roic AI
Solutions
API Docs
MCP
Pricing
Discord
Resources
Toggle navigation menu
Company Search
⌘
K
Toggle theme
Toggle theme
Login
Sign up
Argent BioPharma Limited
L
LSE:RGT
London Stock Exchange
- -
GBp
- -
- -
Argent BioPharma Limited
LSE:RGT
(London Stock Exchange)
Recent
price
- -
P/E
ratio
- -
div
yld
- -
ROIC.AI
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
AUD
42.06
43.6
- -
- -
- -
- -
- -
- -
0.12
0.26
0.54
1.5
1.55
1.84
1.15
- -
Revenue per Share
-244.97
-326.14
156.01
-11.25
-11.83
-33.37
-13.43
-10.2
-8.43
-7.33
-1.91
-14.01
-8.33
-7.93
-7.08
- -
Basic EPS, GAAP
-55.32
-131.1
-27.72
-14.68
-8.4
-2.96
-2.18
-5.54
-5.99
-0.41
-0.3
-0.7
-1.75
-1.05
-0.06
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
-1.11
-320.97
66.78
30.46
118.8
25.11
3.6
17.73
13.22
9.25
6.34
-1.43
3.42
-0.43
-5.26
- -
Book Value per Share
-55.75
-389.08
66.78
30.46
122.59
28.44
6.81
7.7
9.02
4.98
4.77
2.24
3.56
0.79
-2.73
- -
Tangible Book Value per Share
- -
- -
- -
- -
- -
- -
- -
1
1
1
1
1
2
3
3
- -
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
2
3
5
3
1
Sales/Revenue/Turnover
-988.99
-1,052.71
- -
- -
- -
- -
- -
- -
-6,087.36
-2,446.32
-1,377.42
-567.76
-407.37
-301.38
-460.46
-2,049.4
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
1
Depreciation Expense
-2
-3
2
- -
-1
-5
-4
-6
-8
-8
-2
-19
-16
-20
-21
-18
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
-582.4
-748.06
- -
- -
- -
- -
- -
- -
-6,773.31
-2,778.31
-351.91
-931.29
-535.62
-430
-614.71
-1,967.34
Profit Margin (%)
-2
-16
1
- -
- -
- -
- -
4
8
4
2
- -
3
-1
-11
-9
Working Capital
9
1
- -
- -
- -
- -
- -
- -
- -
- -
- -
2
2
2
- -
1
LT Debt
- -
-3
1
1
8
5
2
12
16
13
11
3
14
5
-8
-6
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
-36.01
-18.07
-91.12
-150.85
-105.05
-69.38
-71.14
-25.55
- -
- -
- -
- -
- -
Return on Common Equity (%)
Capital Structure
AUD
•
in mil. unless spec.
No data available
Financial data will appear here once available
Working Capital
AUD
•
in mil. unless spec.
No data available
Financial data will appear here once available
Growth Rates
AUD
•
in mil. unless spec.
(avg. rate of change)
10 years
5 years
1 year
Total Equity
38.16%
-13.92%
-27.48%
Free Cash Flow
70.49%
54.65%
-26.2%
Net Income, GAAP
73%
147.03%
-15.81%
Sales/Revenue/Turnover
- -
43.39%
-73.7%
Total Cash Common Dividend
- -
- -
- -
Quarterly Revenue
AUD
•
in mil. unless spec.
Year
Q1
Q2
Q3
Q4
FY
2022
- -
- -
- -
- -
5
2023
- -
- -
- -
- -
3
2024
- -
- -
- -
- -
1
Quarterly Earnings Per Share
AUD
•
in mil. unless spec.
Year
Q1
Q2
Q3
Q4
FY
2022
- -
- -
- -
- -
-7.93
2023
- -
- -
- -
- -
-7.08
2024
- -
- -
- -
- -
- -
Quarterly Dividends Per Share
AUD
•
in mil. unless spec.
Year
Q1
Q2
Q3
Q4
FY
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
Similar Companies
Business
Toronto
London
Frankfurt
Dubai
Mumbai
Hong Kong
Seoul
Tokyo
Unlock non-US companies
Get Access
Already premium?
Sign in
Summary
Financials
Ratios
Charts
Classic View
Statistics
Stock Splits
Legends:
Stock price
Beta (1.0 Market)
% total return 10/23
Stock
S&P 500
1Y
- -
14.20
3Y
- -
81.12
5Y
- -
68.34